
A Pleasanton biotechnology and pharmaceutical research company has agreed to pay just under $530,000 to the U.S. Department of Justice to resolve civil allegations that it violated the False Claims Act by improperly receiving small business grants while a key employee worked full-time for an outside employer. Cyion Technologies LLC reached the settlement with federal prosecutors, closing out a case tied to National Institutes of Health funding the company drew on between 2019 and 2024, according to the Justice Department.
The case, first reported by Local News Matters, was prosecuted by attorneys with the U.S. Attorney's Office for the Northern District of California. According to the Justice Department, Cyion was accused of receiving two grants from the NIH, awarded in 2017 and 2023, while a key employee simultaneously held a full-time job elsewhere. The settlement, per a Justice Department statement, relates to two Small Business Technology Transfer awards and one Small Business Innovation Research award that Cyion obtained from NIH.
Why Outside Employment Matters for These Grants
Small Business Technology Transfer and Small Business Innovation Research grants prohibit recipients' principal investigators from holding other employment, according to the seed reporting on the case. A principal investigator is the person responsible for the design, implementation and oversight of a research project, per UC Berkeley. NIH's own application instructions reinforce that restriction, stating that primary employment with a small business or research institution precludes full-time employment at another organization, according to NIH grant guidance.
That same guidance notes a possible off-ramp for companies facing a staffing change: a small business may replace the principal investigator on an STTR Phase I or Phase II award, subject to written approval by the Funding Agreement Officer, the NIH instructions state. It is not established in the available case materials whether Cyion sought or received such approval for the grants at issue.
Federal Scrutiny of Research Grants Beyond Pleasanton
Cyion's settlement lands amid a string of other federal actions targeting research institutions over NIH grant compliance. Dana-Farber Cancer Institute agreed in December 2025 to pay $15 million to resolve allegations that it made materially false statements and certifications related to NIH research grants between 2014 and 2024, according to the Justice Department. Separately, the Scripps Research Institute agreed on Sept. 11, 2020, to pay $10 million to settle claims that it improperly charged NIH-funded research grants for time researchers spent on other work, per a Justice Department announcement.
Those two settlements are considerably larger than the sum Cyion paid, though the available evidence does not establish any broader pattern connecting the cases. What is clear from the Justice Department's statement is that Cyion's civil fine topped $500,000, with the agency confirming it received just under $530,000 from the company to close the matter.









